Elligo Health Research utilizes its proprietary IntElligo® technology and EHR data to connect healthcare providers with clinical trials, facilitating access to diverse patient populations across over 600 sites. This approach addresses the challenge of limited patient recruitment in clinical research by streamlining trial management and enhancing site participation.
Funding
$253.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical trials often struggle with patient recruitment, leading to delays and increased costs. Traditional methods of identifying and engaging potential participants are inefficient, particularly in reaching diverse patient populations and healthcare-first sites. This limited access to patients hinders the progress of clinical research and the development of new treatments.
Solution
Elligo Health Research streamlines clinical trial management by connecting sponsors and CROs with a network of healthcare providers and diverse patient populations. Utilizing its IntElligo® technology and EHR data, Elligo facilitates access to patients across healthcare-first sites, elite research sites, and research-enhancing study-level services. The company's Patient Select® model optimizes the intersection of healthcare and research, while the Site Select® model simplifies trial placement through its Study Marketplace technology. Elligo supports traditional, decentralized, and hybrid trials, enabling sites to seamlessly participate in research.
Target Audience
Elligo's primary customers are pharmaceutical sponsors, contract research organizations (CROs), and clinical trial sites seeking to improve patient recruitment and streamline trial management.
Features
- IntElligo® technology leverages EHR data to identify and engage potential clinical trial participants.
- Patient Select® model integrates healthcare and research to optimize patient recruitment.
- Site Select® model simplifies trial placement through a Study Marketplace.
- Access to a network of 115+ hospitals and major health systems, 200+ healthcare-based research sites, and 100+ research-only sites.
- Study-Level Services and Research Partner Services enable sites to seamlessly participate in research.
- Support for traditional, decentralized, and hybrid clinical trials.
- Expertise in 15+ therapeutic areas, including a focus on psychedelic research.